<DOC>
	<DOCNO>NCT01013714</DOCNO>
	<brief_summary>The purpose research study examine effect cardiac sympathetic denervation ( CSD ) surgery life threaten abnormal heart rhythm call ventricular tachycardia ventricular fibrillation lead sudden cardiac death . Subjects ask participate research study recurrent ventricular tachycardia ( least one ICD shock ventricular tachycardia ) undergone least one catheter ablation procedure ventricular tachycardia fibrillation ablatable . The goal study determine whether cardiac sympathetic denervation prevent abnormal heart rhythm occur therefore , prevent , ICD shock painful , show reduce quality life and/or lead depression , particularly period immediately shock .</brief_summary>
	<brief_title>Cardiac Sympathetic Denervation Prevention Ventricular Tachyarrhythmias</brief_title>
	<detailed_description>The purpose study determine bilateral cardiac sympathetic denervation ( CSD ) addition routine care effective routine care treatment ventricular tachycardia fibrillation patient implantable cardioverter defibrillator ( ICDs ) continue episode VT despite drug therapy appropriate , least one catheter ablation procedure . The CSD procedure involve removal part cervical stellate ganglion thoracic ganglia level 2 4 . These ganglion house leave right sided nerve fee heart implicate occurrence fast abnormal rhythm cause defibrillator shock sudden death . Stimulation nerve show increase incidence sudden death fast abnormal heart rhythms lead internal defibrillator shock call ventricular tachycardia/ventricular fibrillation . Removal ganglia nerve animal human study show decrease incidence life threaten abnormal rhythm sudden death.The procedure take less 45 minute side perform endoscopically . We invite patient participate clinical trial undergone least one catheter ablation procedure ventricular tachycardia continue experience recurrent arrhythmia ( ICD shock ) type ventricular tachycardia fibrillation treat catheter ablation procedure . Patients randomize 1:1 fashion either routine care + cardiac sympathetic denervation ( CSD ) routine care without cardiac sympathetic denervation . We ask 90 individual ( approximate age range 18-80 year ) continue experience ICD shock participate research study half individual randomized cardiac sympathetic denervation ( CSD ) surgery .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<criteria>Inclusion Criteria Candidates study must meet ALL follow criterion : Drug refractory ( include betablockers one anti arrhythmic document intolerance toxicity betablockers least one antiarrhythmic ) ventricular tachyarrhythmias lead ICD shock least one catheter ablation procedure VT , OR drug refractory ventricular tachyarrhythmias lead ICD shock amenable clinically appropriate catheter ablation procedure . Clinically appropriate define patient MMVT . Those PMVT idiopathic VF require previous ablation . ICD shock need occur 6 month prior randomization . Epicardial mapping encourage , require , non ischemic cardiomyopathy patient . Qualifying episode must sustain VT require ICD shock . If ischemic cardiomyopathy , myocardial infarction occur one month enrollment . ICD implantation Age great 18 year old . Able willing comply pre followup test requirement . Signed informed consent form . Exclusion Criteria Candidates study EXCLUDED ANY follow condition apply : Active ongoing cardiac ischemia assess : ECG , cardiac enzyme , symptom , coronary angiography evidence significant epicardial coronary stenosis ( &gt; 70 % ) , stress testing . ( Note : positive troponin assay due ICD shock exclusion criterion ) . Revascularization past 90 day . Incessant VT : define sustain VT &gt; 3 hour period despite antiarrhythmic therapy catheter ablation . Any medical nonmedical condition likely prevent completion trial . Contraindication CSD ( i.e . unlikely tolerate general anesthesia , singlelung ventilation , severe pulmonary disease , severe pulmonary hypertension ) previous CSD procedure . Left ventricular assist device status post orthotopic heart transplantation Other disease process likely limit survival le 12 month . Severe thrombocytopenia ( platelet &lt; 50,000 ) coagulopathy ( INR &gt; 2.0 ) due medication reversible cause . Women pregnant ( evidenced pregnancy test premenopausal ) . Unable unwilling comply protocol requirement . Slow VT , rate &lt; 150 bpm . Acute congestive heart failure exacerbation New York Heart Association Class IV heart failure . Known channelopathy long QT syndrome catecholaminergic polymorphic VT . Inability give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Sudden cardiac death</keyword>
	<keyword>Ventricular tachycardia</keyword>
	<keyword>Ventricular fibrillation</keyword>
	<keyword>Cardiomyopathy</keyword>
	<keyword>Internal cardiac defibrillator shock</keyword>
	<keyword>Internal cardiac defibrillator therapy</keyword>
</DOC>